The analgesic efficacy and opioid sparing effect of erector spinae plane block in scoliosis correction surgery: a randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202110576221524

Enrollment

112

Registered

2021-10-07

Start date

2021-11-01

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orthopaedics

Interventions

ESP block

Intravenous patient controlled analgesia

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Either sex Age 10-25 years Idiopathic adolescent scoliosis ASA I or II Scheduled for posterior spinal fusion

Exclusion criteria

Exclusion criteria: Patient refusal Advanced liver and kidney disease Congenital heart disease Severe restrictive lung disease Neuromuscular disease Coagulation disorders Psychiatric disturbances local skin infection chronic pain History of hypersensitivity to any of the study drugs

Design outcomes

Primary

Measure	Time frame
Total postoperative morphine consumption will be calculated as the primary outcome.	—

Secondary

Measure	Time frame
Postoperative visual analogue scale (VAS) score, at 2 hours interval for 24 hours	—

Countries

Egypt

Contacts

Public ContactMohamed Mahdy

Lecturer of Anesthesia and Surgical ICU Faculty of Medicine Mansoura University Egypt

drmohamed.mahdy@yahoo.com00201114781275

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026